Cargando…
Effectiveness of anisodamine for the treatment of critically ill patients with septic shock: a multicentre randomized controlled trial
BACKGROUND: Septic shock is characterized by an uncontrolled inflammatory response and microcirculatory dysfunction. There is currently no specific agent for treating septic shock. Anisodamine is an agent extracted from traditional Chinese medicine with potent anti-inflammatory effects. However, its...
Autores principales: | Yu, Yuetian, Zhu, Cheng, Hong, Yucai, Chen, Lin, Huang, Zhiping, Zhou, Jiancang, Tian, Xin, Liu, Dadong, Ren, Bo, Zhang, Cao, Hu, Caibao, Wang, Xinan, Yin, Rui, Gao, Yuan, Zhang, Zhongheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8474812/ https://www.ncbi.nlm.nih.gov/pubmed/34579741 http://dx.doi.org/10.1186/s13054-021-03774-4 |
Ejemplares similares
-
Anisodamine hydrobromide in the treatment of critically ill patients with septic shock: a multicenter randomized controlled trial
por: Zhang, Fang, et al.
Publicado: (2023) -
Anisodamine microcirulatory effects in septic shock: be aware of cardiac side effects
por: Honore, Patrick M., et al.
Publicado: (2021) -
Beneficial Effects of Anisodamine in Shock Involved Cholinergic Anti-Inflammatory Pathway
por: Zhao, Ting, et al.
Publicado: (2011) -
Kounis Syndrome Induced by Anisodamine: A Case Report
por: Wu, Haoyu, et al.
Publicado: (2020) -
Defining persistent critical illness based on growth trajectories in patients with sepsis
por: Zhang, Zhongheng, et al.
Publicado: (2020)